Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Cold Spring Harbor Symposia on Quantitative Biology|June 29, 1999
Mechanisms of viral activatorsA J Berk, T G Boyer, A N Kapanidis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 2, 2010
Mechanism for prevention of alcohol-induced liver injury by dietary methyl donorsChristine L Powell, Blair U Bradford, Christopher Patrick Craig, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 8, 2010
Interstrain differences in the liver effects of trichloroethylene in a multistrain panel of inbred miceBlair U Bradford, Eric F Lock, Oksana Kosyk, et al.
The American Journal of Physiology|December 22, 1999
CYP2E1 is not involved in early alcohol-induced liver injuryH Kono, B U Bradford, M Yin, et al.
Investigational New Drugs|November 29, 2014
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancerJoshi J Alumkal, Rachel Slottke, Jacob Schwartzman, et al.
ACS Infectious Diseases|September 15, 2016
Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosisMarie H Foss, Sovitj Pou, Patrick M Davidson, et al.
Cancer Research|April 12, 2013
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosisThomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.
Malaria Journal|August 29, 2019
ELQ-331 as a prototype for extremely durable chemoprotection against malariaMartin J Smilkstein, Sovitj Pou, Alina Krollenbrock, et al.
ACS Infectious Diseases|September 21, 2017
Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of MalariaLisa Frueh, Yuexin Li, Michael W Mather, et al.
Pageof 12